- Home
- FTRE vs MRLN Comparison
FTRE vs MRLN Comparison
Compare FTRE & MRLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FTRE | MRLN |
|---|---|---|
| Founded | 1996 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 915.1M |
| IPO Year | 2023 | 2024 |
Fundamental Metrics
Financial Performance| Metric | FTRE | MRLN |
|---|---|---|
| Price | $15.27 | $8.10 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 1 |
| Target Price | $14.06 | ★ $25.00 |
| AVG Volume (30 Days) | 1.4M | ★ 1.5M |
| Earning Date | 05-05-2026 | 10-28-2021 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,723,400,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.09 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 1.00 | N/A |
| 52 Week Low | $3.97 | $5.78 |
| 52 Week High | $18.67 | $17.00 |
Technical Indicators
Market Signals| Indicator | FTRE | MRLN |
|---|---|---|
| Relative Strength Index (RSI) | 69.44 | 47.80 |
| Support Level | $9.01 | $6.07 |
| Resistance Level | $16.20 | $17.00 |
| Average True Range (ATR) | 0.72 | 0.85 |
| MACD | -0.05 | 0.19 |
| Stochastic Oscillator | 87.01 | 76.66 |
Price Performance
Historical ComparisonAbout FTRE Fortrea Holdings Inc.
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion.
About MRLN Merlin Inc. Common Stock
Merlin Inc is focused on developing autonomous flight software for legacy and next-generation airborne systems. Its aircraft-agnostic, AI-based software supports takeoff-to-landing autonomous operations for military and civil aviation programs. The company aims to build an AI-based operating software platform intended to support autonomous flight operations across a range of aircraft types.